Undersøgelsen af Extavia hos patienter med en enkelt demyeliniserende hændelse omfattede 487 patienter, som fik enten Extavia eller placebo i to år.
The study of Extavia in patients with a single demyelinating event involved 487 patients, who received either Extavia or placebo for two years.